MiMedx To Present At Two Healthcare Conferences
2014 STIFEL HEALTHCARE CONFERENCE & CANACCORD|GENUITY MEDICAL TECHNOLOGY AND DIAGNOSTICS FORUM
MARIETTA, Ga., Nov. 5, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it will present at two healthcare conferences in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present at the 2014 Stifel Healthcare Conference on Wednesday, November 19, 2014 at 11:30 am EST at the Palace Hotel. Management will also present at 8:00 am EST on Thursday, November 20, 2014, at the Canaccord|Genuity Forum, which is being held at the Westin Grand Central Hotel. Webcasts of each presentation will be available on the Company's website, www.mimedx.com.
About MiMedx
MiMedx® is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include AmnioFix® and EpiFix®, our tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through our donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® Process, to produce a safe and effective implant. MiMedx® is the leading supplier of amniotic tissue, having supplied over 300,000 allografts to date for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.
SOURCE MiMedx Group, Inc.
Share this article